Andrew Fensome

1.6k total citations
31 papers, 1.2k citations indexed

About

Andrew Fensome is a scholar working on Genetics, Organic Chemistry and Toxicology. According to data from OpenAlex, Andrew Fensome has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 9 papers in Organic Chemistry and 9 papers in Toxicology. Recurrent topics in Andrew Fensome's work include Estrogen and related hormone effects (20 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Endometriosis Research and Treatment (6 papers). Andrew Fensome is often cited by papers focused on Estrogen and related hormone effects (20 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Endometriosis Research and Treatment (6 papers). Andrew Fensome collaborates with scholars based in United States, Canada and Argentina. Andrew Fensome's co-authors include Puwen Zhang, Richard C. Winneker, Jay Wrobel, Zhiming Zhang, Eugene A. Terefenko, Yuan Zhu, Jeffrey Cohen, Jeffrey C. Kern, Casey C. McComas and Matthew R. Yudt and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Andrew Fensome

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Fensome United States 19 684 271 248 160 132 31 1.2k
C. David Jones United States 16 316 0.5× 465 1.7× 235 0.9× 27 0.2× 131 1.0× 28 985
Tracy E. Strecker United States 22 479 0.7× 188 0.7× 462 1.9× 26 0.2× 235 1.8× 33 1.1k
Surinder K. Chander United Kingdom 23 325 0.5× 933 3.4× 853 3.4× 80 0.5× 306 2.3× 38 1.7k
Hiroyuki Masuno Japan 19 219 0.3× 246 0.9× 309 1.2× 123 0.8× 290 2.2× 37 1.1k
Wolfgang Schwede Germany 13 158 0.2× 106 0.4× 204 0.8× 43 0.3× 162 1.2× 34 584
Joanna M. Day United Kingdom 18 162 0.2× 501 1.8× 449 1.8× 35 0.2× 96 0.7× 27 972
M C Bibby United Kingdom 18 307 0.4× 40 0.1× 609 2.5× 66 0.4× 383 2.9× 42 1.2k
Pierre De Clercq Belgium 15 252 0.4× 196 0.7× 208 0.8× 72 0.5× 74 0.6× 40 860
Kazuya Takenouchi Japan 17 242 0.4× 258 1.0× 175 0.7× 33 0.2× 57 0.4× 52 729
Nicola Dobbs United Kingdom 15 118 0.2× 171 0.6× 367 1.5× 103 0.6× 378 2.9× 26 899

Countries citing papers authored by Andrew Fensome

Since Specialization
Citations

This map shows the geographic impact of Andrew Fensome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Fensome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Fensome more than expected).

Fields of papers citing papers by Andrew Fensome

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Fensome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Fensome. The network helps show where Andrew Fensome may publish in the future.

Co-authorship network of co-authors of Andrew Fensome

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Fensome. A scholar is included among the top collaborators of Andrew Fensome based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Fensome. Andrew Fensome is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Page, Karen, Mayte Suárez‐Fariñas, Maria Suprun, et al.. (2020). Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor PF-06700841 Reveal Reduction of Skin Inflammation in Plaque Psoriasis. Journal of Investigative Dermatology. 140(8). 1546–1555.e4. 42 indexed citations
2.
Gerstenberger, Brian S., Mary Ellen Banker, James D. Clark, et al.. (2020). Demonstration of In Vitro to In Vivo Translation of a TYK2 Inhibitor That Shows Cross Species Potency Differences. Scientific Reports. 10(1). 8974–8974. 7 indexed citations
3.
Banfield, Christopher, Matthew Scaramozza, Weidong Zhang, et al.. (2017). The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF‐06700841) in Healthy Subjects and Patients With Plaque Psoriasis. The Journal of Clinical Pharmacology. 58(4). 434–447. 71 indexed citations
4.
McComas, Casey C., Jeffrey Cohen, Christine Huselton, et al.. (2012). Novel progesterone receptor modulators: 4-Aryl-phenylsulfonamides. Bioorganic & Medicinal Chemistry Letters. 22(23). 7119–7122. 2 indexed citations
5.
Fensome, Andrew, Joel Goldberg, Casey C. McComas, et al.. (2010). Structure–activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores. Bioorganic & Medicinal Chemistry Letters. 20(5). 1555–1558. 7 indexed citations
6.
Blass, Benjamin E., Andrew Fensome, Eugene J. Trybulski, et al.. (2009). Selective Kv1.5 Blockers: Development of (R)-1-(Methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a Potential Treatment for Atrial Arrhythmia. Journal of Medicinal Chemistry. 52(21). 6531–6534. 16 indexed citations
7.
Winneker, Richard C., et al.. (2008). A new generation of progesterone receptor modulators. Steroids. 73(7). 689–701. 28 indexed citations
8.
Zhang, Puwen, Jeffrey C. Kern, Eugene A. Terefenko, et al.. (2008). 7-Aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonists. Bioorganic & Medicinal Chemistry. 16(13). 6589–6600. 16 indexed citations
9.
Kern, Jeffrey C., Eugene A. Terefenko, Andrew Fensome, et al.. (2008). 1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5′-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators. Bioorganic & Medicinal Chemistry Letters. 18(18). 5015–5017. 4 indexed citations
10.
McComas, Casey C., A. T. Vu, Paige E. Mahaney, et al.. (2008). Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: A new class of selective norepinephrine reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 4929–4931. 11 indexed citations
11.
Zhang, Puwen, Eugene A. Terefenko, Jeffrey C. Kern, et al.. (2007). 5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist. Bioorganic & Medicinal Chemistry. 15(20). 6556–6564. 18 indexed citations
12.
Kern, Jeffrey C., Eugene A. Terefenko, Andrew Fensome, et al.. (2006). SAR studies of 6-(arylamino)-4,4-disubstituted-1-methyl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones as progesterone receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(1). 189–192. 37 indexed citations
13.
Zhang, Zhiming, Andrea Olland, Yuan Zhu, et al.. (2005). Molecular and Pharmacological Properties of a Potent and Selective Novel Nonsteroidal Progesterone Receptor Agonist Tanaproget. Journal of Biological Chemistry. 280(31). 28468–28475. 66 indexed citations
14.
Terefenko, Eugene A., Jeffrey C. Kern, Andrew Fensome, et al.. (2005). SAR studies of 6-aryl-1,3-dihydrobenzimidazol-2-ones as progesterone receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(15). 3600–3603. 52 indexed citations
15.
Winneker, Richard C., Andrew Fensome, Jay Wrobel, Zhiming Zhang, & Puwen Zhang. (2005). Nonsteroidal Progesterone Receptor Modulators: Structure Activity Relationships. Seminars in Reproductive Medicine. 23(1). 46–57. 18 indexed citations
16.
Collins, Mark A., Reinhold H. W. Bender, Andrew Fensome, et al.. (2004). Novel pyrrole-containing progesterone receptor modulators. Bioorganic & Medicinal Chemistry Letters. 14(9). 2185–2189. 44 indexed citations
17.
Fensome, Andrew, Jay Wrobel, Puwen Zhang, et al.. (2003). Novel 5-aryl-1,3-dihydro-indole-2-thiones. Bioorganic & Medicinal Chemistry Letters. 13(7). 1317–1320. 20 indexed citations
18.
Zhang, Puwen, Eugene A. Terefenko, Andrew Fensome, et al.. (2003). Novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as potent, selective, and orally active nonsteroidal progesterone receptor agonists. Bioorganic & Medicinal Chemistry Letters. 13(7). 1313–1316. 56 indexed citations
19.
Zhang, Puwen, Eugene A. Terefenko, Andrew Fensome, et al.. (2002). Potent nonsteroidal progesterone receptor agonists: Synthesis and SAR study of 6-aryl benzoxazines. Bioorganic & Medicinal Chemistry Letters. 12(5). 787–790. 104 indexed citations
20.
Fensome, Andrew, Reinhold H. W. Bender, Jeffrey Cohen, et al.. (2002). New progesterone receptor antagonists: 3,3-disubstituted-5-aryloxindoles. Bioorganic & Medicinal Chemistry Letters. 12(23). 3487–3490. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. David Jones Breakdown of academic impact, for papers by Tracy E. Strecker Breakdown of academic impact, for papers by Surinder K. Chander Breakdown of academic impact, for papers by Hiroyuki Masuno Breakdown of academic impact, for papers by Wolfgang Schwede Breakdown of academic impact, for papers by Joanna M. Day Breakdown of academic impact, for papers by M C Bibby Breakdown of academic impact, for papers by Pierre De Clercq Breakdown of academic impact, for papers by Kazuya Takenouchi Breakdown of academic impact, for papers by Nicola Dobbs
Rankless by CCL
2026